Vcanbio Cell & Gene Engineering Corp Ltd (600645) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥103.70 Million ≈ $15.17 Million USD) by net assets (CN¥3.76 Billion ≈ $550.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Vcanbio Cell & Gene Engineering Corp Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Vcanbio Cell & Gene Engineering Corp Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Vcanbio Cell & Gene Engineering Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vcanbio Cell & Gene Engineering Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vcanbio Cell & Gene Engineering Corp Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sensirion Holding AG SW:SENS	0.098x
immatics biotechnologies GmbH F:4A3	-0.121x
WIZZ AIR HLDG.UNSP.ADR/4 F:WI20	N/A
Xinxiang Richful Lube Additive Co. Ltd SHE:300910	0.050x
Alexanders Inc NYSE:ALX	0.075x
secunet Security Networks Aktiengesellschaft F:YSN	-0.009x
The India Cements Limited NSE:INDIACEM	-0.019x
Hornbach Holding VZO O.N. XETRA:HBH	0.016x

Annual Cash Flow Conversion Efficiency for Vcanbio Cell & Gene Engineering Corp Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Vcanbio Cell & Gene Engineering Corp Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see 600645 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.75 Billion ≈ $549.45 Million	CN¥313.63 Million ≈ $45.89 Million	0.084x	+7.17%
2024-12-31	CN¥3.66 Billion ≈ $535.44 Million	CN¥285.19 Million ≈ $41.73 Million	0.078x	-0.99%
2023-12-31	CN¥3.80 Billion ≈ $555.86 Million	CN¥299.02 Million ≈ $43.76 Million	0.079x	+9.82%
2022-12-31	CN¥3.65 Billion ≈ $534.64 Million	CN¥261.89 Million ≈ $38.32 Million	0.072x	-21.10%
2021-12-31	CN¥3.53 Billion ≈ $516.95 Million	CN¥320.96 Million ≈ $46.97 Million	0.091x	+30.22%
2020-12-31	CN¥3.50 Billion ≈ $512.51 Million	CN¥244.35 Million ≈ $35.76 Million	0.070x	-0.02%
2019-12-31	CN¥3.46 Billion ≈ $506.41 Million	CN¥241.49 Million ≈ $35.34 Million	0.070x	+60.09%
2018-12-31	CN¥2.98 Billion ≈ $436.71 Million	CN¥130.08 Million ≈ $19.04 Million	0.044x	+1.38%
2017-12-31	CN¥1.63 Billion ≈ $239.17 Million	CN¥70.27 Million ≈ $10.28 Million	0.043x	-47.58%
2016-12-31	CN¥1.75 Billion ≈ $256.34 Million	CN¥143.67 Million ≈ $21.02 Million	0.082x	+1587.16%
2015-12-31	CN¥1.68 Billion ≈ $246.10 Million	CN¥8.17 Million ≈ $1.20 Million	0.005x	-97.46%
2014-12-31	CN¥1.16 Billion ≈ $169.20 Million	CN¥221.45 Million ≈ $32.41 Million	0.192x	+14.17%
2013-12-31	CN¥660.07 Million ≈ $96.59 Million	CN¥110.72 Million ≈ $16.20 Million	0.168x	-32.93%
2012-12-31	CN¥281.54 Million ≈ $41.20 Million	CN¥70.41 Million ≈ $10.30 Million	0.250x	-39.12%
2011-12-31	CN¥268.85 Million ≈ $39.34 Million	CN¥110.44 Million ≈ $16.16 Million	0.411x	-42.99%
2010-12-31	CN¥244.13 Million ≈ $35.72 Million	CN¥175.93 Million ≈ $25.74 Million	0.721x	+38.01%
2009-12-31	CN¥239.23 Million ≈ $35.01 Million	CN¥124.92 Million ≈ $18.28 Million	0.522x	+10.06%
2008-12-31	CN¥256.31 Million ≈ $37.51 Million	CN¥121.60 Million ≈ $17.79 Million	0.474x	-21.23%
2007-12-31	CN¥185.42 Million ≈ $27.13 Million	CN¥111.68 Million ≈ $16.34 Million	0.602x	+45.63%
2006-12-31	CN¥184.04 Million ≈ $26.93 Million	CN¥76.12 Million ≈ $11.14 Million	0.414x	-19.44%
2005-12-31	CN¥164.95 Million ≈ $24.14 Million	CN¥84.69 Million ≈ $12.39 Million	0.513x	+175.49%
2004-12-31	CN¥309.95 Million ≈ $45.36 Million	CN¥57.76 Million ≈ $8.45 Million	0.186x	+62.98%
2003-12-31	CN¥365.02 Million ≈ $53.41 Million	CN¥41.74 Million ≈ $6.11 Million	0.114x	+377.40%
2002-12-31	CN¥357.83 Million ≈ $52.36 Million	CN¥-14.75 Million ≈ $-2.16 Million	-0.041x	+75.21%
2001-12-31	CN¥414.06 Million ≈ $60.59 Million	CN¥-68.84 Million ≈ $-10.07 Million	-0.166x	-327.53%
2000-12-31	CN¥433.95 Million ≈ $63.50 Million	CN¥31.71 Million ≈ $4.64 Million	0.073x	+632.86%
1999-12-31	CN¥414.12 Million ≈ $60.60 Million	CN¥4.13 Million ≈ $604.18K	0.010x	+112.92%
1998-12-31	CN¥416.47 Million ≈ $60.94 Million	CN¥-32.14 Million ≈ $-4.70 Million	-0.077x	--

About Vcanbio Cell & Gene Engineering Corp Ltd

SHG:600645 China Biotechnology

Market Cap

$1.26 Billion

CN¥8.59 Billion CNY

Market Cap Rank

#8087 Global

#1944 in China

Share Price

CN¥18.35

Change (1 day)

+0.82%

52-Week Range

CN¥18.19 - CN¥32.94

All Time High

CN¥68.93